Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai Jiaoda Onlly CoSHSE:600530 -3.92%39 FCF Margin % is 8.86% as of Mar. 2026, which is 23% below its 10-year median of 11.47. GuruFocus rates SHSE:600530 with a GF Score™ of 39/100 and a GF Value™ of ¥2.95 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 962 Drug Manufacturers companies, Shanghai Jiaoda Onlly Co ranks better than 85.76% on this metric.
The historical rank and industry rank for Shanghai Jiaoda Onlly Co's FCF Margin % or its related term are showing as below:
SHSE:600530'
s FCF Margin % Range Over the Past 10 Years
Min: -26.4 Med: 11.47 Max: 25.8
Current: 17.44
During the past 13 years, the highest FCF Margin % of Shanghai Jiaoda Onlly Co was 25.80%. The lowest was -26.40%. And the median was 11.47%.
SHSE:600530's FCF Margin % is ranked better than 85.76% of 962
companies
in the Drug Manufacturers industry
Industry Median: 2.585
vs SHSE:600530: 17.44
Shanghai Jiaoda Onlly Co FCF Margin % Related Terms
Shanghai Jiaoda Onlly Co FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Jiaoda Onlly Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Jiaoda Onlly Co FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shanghai Jiaoda Onlly Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Shanghai Jiaoda Onlly Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Jiaoda Onlly Co (SHSE:600530) has a FCF Margin % of 8.86% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shanghai Jiaoda Onlly Co and its competitors. This is 23% below median its historical median of 11.47. According to the industry distribution chart, Shanghai Jiaoda Onlly Co ranks #137 out of 962 companies in the Drug Manufacturers industry, placing it in the top 14.2%.
Is Shanghai Jiaoda Onlly Co's FCF Margin % too high?
Shanghai Jiaoda Onlly Co's current FCF Margin % of 8.86% is 23% below median its 10-year median of 11.47. The Drug Manufacturers industry median FCF Margin % is 2.59. Shanghai Jiaoda Onlly Co's value of 8.86% is 242.7% above this industry median. Based on the distribution chart, Shanghai Jiaoda Onlly Co ranks #137 out of 962 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai Jiaoda Onlly Co has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Jiaoda Onlly Co's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Shanghai Jiaoda Onlly Co ranks #137 out of 962 companies for FCF Margin %. This places Shanghai Jiaoda Onlly Co in the top 14% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.59. Shanghai Jiaoda Onlly Co's value of 8.86% is 242.7% above this benchmark. While the company's 10-year median is 11.47 vs. the industry median of 2.59, Shanghai Jiaoda Onlly Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.59, based on 962 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Jiaoda Onlly Co's current FCF Margin % of 8.86% is 242.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shanghai Jiaoda Onlly Co and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Jiaoda Onlly Co's current FCF Margin % is 8.86%, which is 23% below median its own 10-year median of 11.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Jiaoda Onlly Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Jiaoda Onlly Co (SHSE:600530) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥2.95, compared to a current price of ¥4.66 — trading 58% above its estimated fair value. The current FCF Margin % is 8.86%, which is 23% below median its 10-year median of 11.47 and 242.7% above the Drug Manufacturers industry median of 2.59. Shanghai Jiaoda Onlly Co's overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Shanghai Jiaoda Onlly Co (SHSE:600530), the current FCF Margin % is 8.86% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Jiaoda Onlly Co (SHSE:600530) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Jiaoda Onlly Co stock appears to be overvalued.
The current stock price of ¥4.66 is trading 58% above its estimated GF Value™ of ¥2.95.
GuruFocus considers Shanghai Jiaoda Onlly Co to be Significantly Overvalued.
Key valuation signals for SHSE:600530:
FCF Margin %: 8.86% (23% below median its 10-year median of 11.47)
GF Value™: ¥2.95 vs. price of ¥4.66 (58% above fair value)
Industry Position: 242.7% above the Drug Manufacturers median (#137 of 962)
No single metric tells the full story. See the SHSE:600530 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Jiaoda Onlly Co Ltd is engaged in producing and distributing healthcare products. The company is also involved in real estate and financial investment. Its main products are biological products and healthcare products.
39GF Score
Get the complete analysis for SHSE:600530
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600530 has been successfully added to your 
